Active Studies

The purpose of this study is to further refine the NIDA PhAB Phenotype Battery with specific attention paid to sub-typing participant characteristics in order to create better treatments for substance users in the future. The goal is for this battery to be efficiently embedded into future clinical trials.

Randomized, Placebo-Controlled Trial of Extended-Release Naltrexone and Monthly Extended-Release Buprenorphine for Cocaine Use Disorder (CURB-2)

Expression of stress markers in MSM living with HIV receiving contingency management for methamphetamine use disorder (a.k.a "EXPRESS+")

A Phase 2, Open-Label, Multicenter, Randomized Study to Evaluate the Pharmacokinetics and Safety of Twice Yearly Long-Acting Subcutaneous Lenacapavir for Pre-Exposure Prophylaxis in People Who Inject Drugs.